Novo Nordisk, Eli Lilly slide after Trump comments on weight loss drug pricing
Inson Paul Joseph, Chief People Officer at IBEX Ltd (NASDAQ:IBEX), sold 3,831 common shares of the company on September 12, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The transaction comes as IBEX shares have surged over 80% year-to-date, with the stock trading near its 52-week high of $42.99. According to InvestingPro, management has been actively buying back shares, suggesting confidence in the company’s outlook. The shares were sold at a price of $38.94, for a total transaction value of $149,179.
Following the transaction, Inson Paul Joseph directly owns 3,266 shares of IBEX Ltd.
In other recent news, IBEX Ltd reported strong financial results for the fourth quarter of 2025, surpassing market expectations. The company achieved an earnings per share of $0.87, exceeding the forecasted $0.70. Additionally, revenue for the quarter reached $147.1 million, significantly above the predicted $129.21 million. These results highlight the company’s robust performance and growth trajectory. In another development, RBC Capital raised its price target for IBEX to $39 from $31, maintaining a Sector Perform rating. This adjustment comes as a response to IBEX’s accelerated revenue growth, which increased by 18% year-over-year. RBC Capital noted that the company’s growth is supported by sustainable expansion through existing clients and geographic expansion with its second-largest client. These recent developments reflect positively on IBEX’s strategic initiatives and financial health.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.